Table 1. [The FDA (2019) Drug Label for Clobazam: Recommended Total Daily Dosing by Weight Group]. - Medical Genetics Summaries

	Less than or equal to 30 kg body weight	Greater than 30 kg body weight	CYP2C19 poor metabolizers
Starting dose	5 mg	10 mg	In patients known to be CYP2C19 poor metabolizers, the starting dose should be 5 mg/day and dose titration should proceed slowly according to weight, but to half the recommended total daily doses presented in this table, as tolerated. If necessary, and based upon clinical response, an additional titration to the maximum dose (20 mg/day or 40 mg/day, depending on the weight group) may be started on day 21.
Starting day 7	10 mg	20 mg
Starting day 14	20 mg	40 mg

From: Clobazam Therapy and CYP2C19 Genotype

Medical Genetics Summaries [Internet].

Pratt VM, Scott SA, Pirmohamed M, et al., editors.

Bethesda (MD): National Center for Biotechnology Information (US); 2012-.

All Medical Genetics Summaries content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license which permits copying, distribution, and adaptation of the work, provided the original work is properly cited and any changes from the original work are properly indicated. Any altered, transformed, or adapted form of the work may only be distributed under the same or similar license to this one.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.